Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Choledocholithiasis | Research

Epidemiology and outcomes of choledocholithiasis and cholangitis in the United States: trends and urban-rural variations

Authors: Suqing Li, Leonardo Guizzetti, Christopher Ma, Abdel Aziz Shaheen, Elijah Dixon, Chad Ball, Sachin Wani, Nauzer Forbes

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

Gallstone disease poses a significant health burden in the United States. Choledocholithiasis and cholangitis are common complications of gallstone disease for which data on current epidemiological trends are lacking. We aimed to evaluate temporal changes in hospitalization, management, and outcomes for patients with choledocholithiasis and cholangitis.

Methods

The National Inpatient Sample was used to identify discharges for choledocholithiasis and cholangitis between 2005 and 2014. Temporal trends were evaluated via annual percent changes (APCs). Joinpoint regression was used to assess inflection points. Multivariable regression models were used to evaluate associations of interest.

Results

From 189,362 unweighted discharges for choledocholithiasis and/or cholangitis, there was an increase in discharges for choledocholithiasis (APC 2.3%, 95% confidence intervals, CI, 1.9–2.7%) and cholangitis (APC 1.5%, 95% CI 0.7–2.2%). Procedural interventions were more likely at urban hospitals for choledocholithiasis (adjusted odds ratio, aOR, 2.94, 95% CI 2.72 to 3.17) and cholangitis (aOR 2.97, 95% CI 2.50 to 3.54). In-hospital mortality significantly decreased annually for choledocholithiasis (aOR 0.90, 95% CI 0.88 to 0.93) and cholangitis (aOR 0.93, 95% CI 0.89 to 0.97). In-hospital mortality between rural and urban centers was comparable for choledocholithiasis (aOR 1.16, 95% CI 0.89 to 1.52) and cholangitis (aOR 1.12, 95% CI 0.72 to 1.72).

Conclusions

Hospitalizations for choledocholithiasis and cholangitis have increased between 2005 and 2014, reflecting a growing burden of gallstone disease. Hospital mortality between urban and rural centers is similar, however urban centers have a higher rate of procedural interventions suggesting limitations to accessing procedural interventions at rural centers.
Appendix
Available only for authorised users
Literature
2.
go back to reference Buxbaum JL, Abbas Fehmi SM, Sultan S, Fishman DS, Qumseya BJ, Cortessis VK, et al. ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis. Gastrointest Endosc. 2019;89(6):1075–105e15.PubMedPubMedCentralCrossRef Buxbaum JL, Abbas Fehmi SM, Sultan S, Fishman DS, Qumseya BJ, Cortessis VK, et al. ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis. Gastrointest Endosc. 2019;89(6):1075–105e15.PubMedPubMedCentralCrossRef
3.
go back to reference Peery AF, Crockett SD, Murphy CC, Jensen ET, Kim HP, Egberg MD, et al. Burden and cost of gastrointestinal, liver, and pancreatic Diseases in the United States: Update 2021. Gastroenterology. 2022;162(2):621–44.PubMedCrossRef Peery AF, Crockett SD, Murphy CC, Jensen ET, Kim HP, Egberg MD, et al. Burden and cost of gastrointestinal, liver, and pancreatic Diseases in the United States: Update 2021. Gastroenterology. 2022;162(2):621–44.PubMedCrossRef
4.
go back to reference Frossard JL, Morel PM. Detection and management of bile duct stones. Gastrointest Endosc. 2010;72(4):808–16.PubMedCrossRef Frossard JL, Morel PM. Detection and management of bile duct stones. Gastrointest Endosc. 2010;72(4):808–16.PubMedCrossRef
5.
go back to reference Neuhaus H, Feussner H, Ungeheuer A, Hoffmann W, Siewert JR, Classen M. Prospective evaluation of the Use of Endoscopic Retrograde Cholangiography prior to laparoscopic cholecystectomy. Endoscopy. 1992;24(09):745–9.PubMedCrossRef Neuhaus H, Feussner H, Ungeheuer A, Hoffmann W, Siewert JR, Classen M. Prospective evaluation of the Use of Endoscopic Retrograde Cholangiography prior to laparoscopic cholecystectomy. Endoscopy. 1992;24(09):745–9.PubMedCrossRef
6.
go back to reference Lacaine F, Corlette MB, Bismuth H. Preoperative evaluation of the risk of common bile Duct Stones. Arch Surg. 1980;115(9):1114–6.PubMedCrossRef Lacaine F, Corlette MB, Bismuth H. Preoperative evaluation of the risk of common bile Duct Stones. Arch Surg. 1980;115(9):1114–6.PubMedCrossRef
7.
go back to reference Buxbaum JL, Buitrago C, Lee A, Elmunzer BJ, Riaz A, Ceppa EP, et al. ASGE guideline on the management of cholangitis. Gastrointest Endosc. 2021;94(2):207–21e14.PubMedCrossRef Buxbaum JL, Buitrago C, Lee A, Elmunzer BJ, Riaz A, Ceppa EP, et al. ASGE guideline on the management of cholangitis. Gastrointest Endosc. 2021;94(2):207–21e14.PubMedCrossRef
8.
go back to reference Lai EC, Mok FP, Tan ES, Lo CM, Fan ST, You KT, et al. Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med. 1992;326(24):1582–6.PubMedCrossRef Lai EC, Mok FP, Tan ES, Lo CM, Fan ST, You KT, et al. Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med. 1992;326(24):1582–6.PubMedCrossRef
9.
go back to reference Boni L, Huo B, Alberici L, Ricci C, Tsokani S, Mavridis D, et al. EAES rapid guideline: updated systematic review, network meta-analysis, CINeMA and GRADE assessment, and evidence-informed european recommendations on the management of common bile duct stones. Surg Endosc. 2022;36(11):7863–76.PubMedCrossRef Boni L, Huo B, Alberici L, Ricci C, Tsokani S, Mavridis D, et al. EAES rapid guideline: updated systematic review, network meta-analysis, CINeMA and GRADE assessment, and evidence-informed european recommendations on the management of common bile duct stones. Surg Endosc. 2022;36(11):7863–76.PubMedCrossRef
10.
go back to reference Rogers SJ, Cello JP, Horn JK, Siperstein AE, Schecter WP, Campbell AR, et al. Prospective randomized trial of LC + LCBDE vs ERCP/S + LC for common bile duct stone disease. Arch Surg. 2010;145(1):28–33.PubMedCrossRef Rogers SJ, Cello JP, Horn JK, Siperstein AE, Schecter WP, Campbell AR, et al. Prospective randomized trial of LC + LCBDE vs ERCP/S + LC for common bile duct stone disease. Arch Surg. 2010;145(1):28–33.PubMedCrossRef
11.
go back to reference Oh CH, Dong SH. Recent advances in the management of difficult bile-duct stones: a focus on single-operator cholangioscopy-guided lithotripsy. Korean J Intern Med. 2021;36(2):235–46.PubMedCrossRef Oh CH, Dong SH. Recent advances in the management of difficult bile-duct stones: a focus on single-operator cholangioscopy-guided lithotripsy. Korean J Intern Med. 2021;36(2):235–46.PubMedCrossRef
12.
go back to reference Miura F, Okamoto K, Takada T, Strasberg SM, Asbun HJ, Pitt HA, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25(1):31–40.PubMedCrossRef Miura F, Okamoto K, Takada T, Strasberg SM, Asbun HJ, Pitt HA, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25(1):31–40.PubMedCrossRef
13.
go back to reference Shelton J, Kummerow K, Phillips S, Griffin M, Holzman MD, Nealon W, et al. An urban-rural blight? Choledocholithiasis presentation and treatment. J Surg Res. 2012;173(2):193–7.PubMedCrossRef Shelton J, Kummerow K, Phillips S, Griffin M, Holzman MD, Nealon W, et al. An urban-rural blight? Choledocholithiasis presentation and treatment. J Surg Res. 2012;173(2):193–7.PubMedCrossRef
14.
go back to reference Poulose BK, Phillips S, Nealon W, Shelton J, Kummerow K, Penson D, et al. Choledocholithiasis management in rural America: health disparity or health opportunity? J Surg Res. 2011;170(2):214–9.PubMedCrossRef Poulose BK, Phillips S, Nealon W, Shelton J, Kummerow K, Penson D, et al. Choledocholithiasis management in rural America: health disparity or health opportunity? J Surg Res. 2011;170(2):214–9.PubMedCrossRef
15.
go back to reference Baucom RB, Feurer ID, Shelton JS, Kummerow K, Holzman MD, Poulose BK. Surgeons, ERCP, and laparoscopic common bile duct exploration: do we need a standard approach for common bile duct stones? Surg Endosc. 2016;30(2):414–23.PubMedCrossRef Baucom RB, Feurer ID, Shelton JS, Kummerow K, Holzman MD, Poulose BK. Surgeons, ERCP, and laparoscopic common bile duct exploration: do we need a standard approach for common bile duct stones? Surg Endosc. 2016;30(2):414–23.PubMedCrossRef
16.
go back to reference Using AHRRDE, the HCUP National Inpatient Sample to Estimate Trends. 2015. In: HCUP Methods Series Report #2006-05 [Internet]. U.S. Agency for Healthcare Research and Quality. Using AHRRDE, the HCUP National Inpatient Sample to Estimate Trends. 2015. In: HCUP Methods Series Report #2006-05 [Internet]. U.S. Agency for Healthcare Research and Quality.
17.
go back to reference Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51.PubMedCrossRef Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51.PubMedCrossRef
18.
go back to reference Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, et al. Burden and cost of gastrointestinal, liver, and pancreatic Diseases in the United States: Update 2018. Gastroenterology. 2019;156(1):254–72e11.PubMedCrossRef Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, et al. Burden and cost of gastrointestinal, liver, and pancreatic Diseases in the United States: Update 2018. Gastroenterology. 2019;156(1):254–72e11.PubMedCrossRef
19.
go back to reference Unalp-Arida A, Ruhl C. The Burden of Gallstone Disease in the United States Population. medRxiv. 2022. 2022.07.08.22277386. Unalp-Arida A, Ruhl C. The Burden of Gallstone Disease in the United States Population. medRxiv. 2022. 2022.07.08.22277386.
21.
go back to reference Li S, Guizzetti L, Ma C, Shaheen AA, Dixon E, Ball C et al. Epidemiology and outcomes of symptomatic cholelithiasis and cholecystitis in the USA: Trends and Urban-Rural Variations. J Gastrointest Surg. 2023. Li S, Guizzetti L, Ma C, Shaheen AA, Dixon E, Ball C et al. Epidemiology and outcomes of symptomatic cholelithiasis and cholecystitis in the USA: Trends and Urban-Rural Variations. J Gastrointest Surg. 2023.
22.
go back to reference Ahmed A, Cheung RC, Keeffe EB. Management of gallstones and their complications. Am Family Phys. 2000;61(6):1673–80. 87 – 8. Ahmed A, Cheung RC, Keeffe EB. Management of gallstones and their complications. Am Family Phys. 2000;61(6):1673–80. 87 – 8.
23.
go back to reference Copelan A, Kapoor BS, Choledocholithiasis. Diagnosis and management. Tech Vasc Interv Radiol. 2015;18(4):244–55.PubMedCrossRef Copelan A, Kapoor BS, Choledocholithiasis. Diagnosis and management. Tech Vasc Interv Radiol. 2015;18(4):244–55.PubMedCrossRef
24.
go back to reference Oak JH, Paik CN, Chung WC, Lee K-M, Yang JM. Risk factors for recurrence of symptomatic common bile Duct Stones after Cholecystectomy. Gastroenterol Res Pract. 2012;2012:417821.PubMedPubMedCentralCrossRef Oak JH, Paik CN, Chung WC, Lee K-M, Yang JM. Risk factors for recurrence of symptomatic common bile Duct Stones after Cholecystectomy. Gastroenterol Res Pract. 2012;2012:417821.PubMedPubMedCentralCrossRef
25.
go back to reference Chung EJ, Kim MH, Lee SS, Lee SK. Primary vs. secondary common bile duct stones: apples and oranges. Endoscopy. 2003;35(1):92. author reply 3.PubMedCrossRef Chung EJ, Kim MH, Lee SS, Lee SK. Primary vs. secondary common bile duct stones: apples and oranges. Endoscopy. 2003;35(1):92. author reply 3.PubMedCrossRef
26.
go back to reference Feng R, Zhang T, Kayani MuR, Wang Z, Shen Y, Su KL et al. Patients with primary and secondary bile Duct Stones Harbor distinct biliary microbial composition and metabolic potential. Front Cell Infect Microbiol. 2022;12. Feng R, Zhang T, Kayani MuR, Wang Z, Shen Y, Su KL et al. Patients with primary and secondary bile Duct Stones Harbor distinct biliary microbial composition and metabolic potential. Front Cell Infect Microbiol. 2022;12.
27.
go back to reference Chowbey P, Sharma A, Goswami A, Afaque Y, Najma K, Baijal M, et al. Residual gallbladder stones after cholecystectomy: a literature review. J Minim Access Surg. 2015;11(4):223–30.PubMedPubMedCentralCrossRef Chowbey P, Sharma A, Goswami A, Afaque Y, Najma K, Baijal M, et al. Residual gallbladder stones after cholecystectomy: a literature review. J Minim Access Surg. 2015;11(4):223–30.PubMedPubMedCentralCrossRef
28.
go back to reference Sabour AF, Matsushima K, Love BE, Alicuben ET, Schellenberg MA, Inaba K, et al. Nationwide trends in the use of subtotal cholecystectomy for acute cholecystitis. Surgery. 2020;167(3):569–74.PubMedCrossRef Sabour AF, Matsushima K, Love BE, Alicuben ET, Schellenberg MA, Inaba K, et al. Nationwide trends in the use of subtotal cholecystectomy for acute cholecystitis. Surgery. 2020;167(3):569–74.PubMedCrossRef
29.
go back to reference Donnellan E, Coulter J, Mathew C, Choynowski M, Flanagan L, Bucholc M, et al. A meta-analysis of the use of intraoperative cholangiography; time to revisit our approach to cholecystectomy? Surg Open Sci. 2021;3:8–15.PubMedCrossRef Donnellan E, Coulter J, Mathew C, Choynowski M, Flanagan L, Bucholc M, et al. A meta-analysis of the use of intraoperative cholangiography; time to revisit our approach to cholecystectomy? Surg Open Sci. 2021;3:8–15.PubMedCrossRef
30.
go back to reference Altieri MS, Yang J, Obeid N, Zhu C, Talamini M, Pryor A. Increasing bile duct injury and decreasing utilization of intraoperative cholangiogram and common bile duct exploration over 14 years: an analysis of outcomes in New York State. Surg Endosc. 2018;32(2):667–74.PubMedCrossRef Altieri MS, Yang J, Obeid N, Zhu C, Talamini M, Pryor A. Increasing bile duct injury and decreasing utilization of intraoperative cholangiogram and common bile duct exploration over 14 years: an analysis of outcomes in New York State. Surg Endosc. 2018;32(2):667–74.PubMedCrossRef
31.
go back to reference Möller M, Gustafsson U, Rasmussen F, Persson G, Thorell A. Natural course vs interventions to clear common bile Duct Stones: data from the Swedish Registry for Gallstone surgery and endoscopic Retrograde Cholangiopancreatography (GallRiks). JAMA Surg. 2014;149(10):1008–13.PubMedCrossRef Möller M, Gustafsson U, Rasmussen F, Persson G, Thorell A. Natural course vs interventions to clear common bile Duct Stones: data from the Swedish Registry for Gallstone surgery and endoscopic Retrograde Cholangiopancreatography (GallRiks). JAMA Surg. 2014;149(10):1008–13.PubMedCrossRef
32.
go back to reference Hakuta R, Hamada T, Nakai Y, Oyama H, Kanai S, Suzuki T, et al. Natural history of asymptomatic bile duct stones and association of endoscopic treatment with clinical outcomes. J Gastroenterol. 2020;55(1):78–85.PubMedCrossRef Hakuta R, Hamada T, Nakai Y, Oyama H, Kanai S, Suzuki T, et al. Natural history of asymptomatic bile duct stones and association of endoscopic treatment with clinical outcomes. J Gastroenterol. 2020;55(1):78–85.PubMedCrossRef
33.
go back to reference Cai JS, Qiang S, Bao-Bing Y. Advances of recurrent risk factors and management of choledocholithiasis. Scand J Gastroenterol. 2017;52(1):34–43.PubMedCrossRef Cai JS, Qiang S, Bao-Bing Y. Advances of recurrent risk factors and management of choledocholithiasis. Scand J Gastroenterol. 2017;52(1):34–43.PubMedCrossRef
34.
go back to reference Al-Habbal Y, Reid I, Tiang T, Houli N, Lai B, McQuillan T, et al. Retrospective comparative analysis of choledochoscopic bile duct exploration versus ERCP for bile duct stones. Sci Rep. 2020;10(1):14736.PubMedPubMedCentralCrossRef Al-Habbal Y, Reid I, Tiang T, Houli N, Lai B, McQuillan T, et al. Retrospective comparative analysis of choledochoscopic bile duct exploration versus ERCP for bile duct stones. Sci Rep. 2020;10(1):14736.PubMedPubMedCentralCrossRef
35.
go back to reference Hall MJ, Owings M. Rural and urban hospitals’ role in providing inpatient care, 2010. NCHS Data Brief. 2014(147):1–8. Hall MJ, Owings M. Rural and urban hospitals’ role in providing inpatient care, 2010. NCHS Data Brief. 2014(147):1–8.
36.
go back to reference Touzin E, Decker C, Kelly L, Minty B. Gallbladder disease in northwestern Ontario: the case for Canada’s first rural ERCP program. Can J Rural Med. 2011;16(2):55–60.PubMed Touzin E, Decker C, Kelly L, Minty B. Gallbladder disease in northwestern Ontario: the case for Canada’s first rural ERCP program. Can J Rural Med. 2011;16(2):55–60.PubMed
37.
go back to reference Wandling MW, Hungness ES, Pavey ES, Stulberg JJ, Schwab B, Yang AD, et al. Nationwide Assessment of Trends in Choledocholithiasis Management in the United States from 1998 to 2013. JAMA Surg. 2016;151(12):1125–30.PubMedCrossRef Wandling MW, Hungness ES, Pavey ES, Stulberg JJ, Schwab B, Yang AD, et al. Nationwide Assessment of Trends in Choledocholithiasis Management in the United States from 1998 to 2013. JAMA Surg. 2016;151(12):1125–30.PubMedCrossRef
38.
go back to reference Rogers SJ, Cello JP, Horn JK, Siperstein AE, Schecter WP, Campbell AR, et al. Prospective randomized trial of LC + LCBDE vs ERCP/S + LC for common bile Duct Stone Disease. Arch Surg. 2010;145(1):28–33.PubMedCrossRef Rogers SJ, Cello JP, Horn JK, Siperstein AE, Schecter WP, Campbell AR, et al. Prospective randomized trial of LC + LCBDE vs ERCP/S + LC for common bile Duct Stone Disease. Arch Surg. 2010;145(1):28–33.PubMedCrossRef
39.
go back to reference Berci G, Hunter J, Morgenstern L, Arregui M, Brunt M, Carroll B, et al. Laparoscopic cholecystectomy: first, do no harm; second, take care of bile duct stones. Surg Endosc. 2013;27(4):1051–4.PubMedCrossRef Berci G, Hunter J, Morgenstern L, Arregui M, Brunt M, Carroll B, et al. Laparoscopic cholecystectomy: first, do no harm; second, take care of bile duct stones. Surg Endosc. 2013;27(4):1051–4.PubMedCrossRef
40.
go back to reference Warner RL, Coleman KC, Musgrove KA, Bardes JM, Borgstrom DC, Grabo DJ. A review of general surgery resident experience in common bile duct exploration in the ERCP era. Am J Surg. 2020;220(4):899–904.PubMedCrossRef Warner RL, Coleman KC, Musgrove KA, Bardes JM, Borgstrom DC, Grabo DJ. A review of general surgery resident experience in common bile duct exploration in the ERCP era. Am J Surg. 2020;220(4):899–904.PubMedCrossRef
41.
go back to reference Campagna RAJ, Belette AM, Holmstrom AL, Halverson AL, Santos BF, Hungness ES, et al. Addressing the gap in laparoscopic common bile duct exploration training for rural surgeons: imparting procedural ability is not enough. Surg Endosc. 2021;35(9):5140–6.PubMedCrossRef Campagna RAJ, Belette AM, Holmstrom AL, Halverson AL, Santos BF, Hungness ES, et al. Addressing the gap in laparoscopic common bile duct exploration training for rural surgeons: imparting procedural ability is not enough. Surg Endosc. 2021;35(9):5140–6.PubMedCrossRef
42.
go back to reference Abbas A, Sethi S, Vidyarthi G, Taunk P. Predictors of Post ERCP Pancreatitis: analysis of more than half a million ERCPs performed Nationwide over the last 15 years: 57. Official J Am Coll Gastroenterol | ACG. 2018;113:35. Abbas A, Sethi S, Vidyarthi G, Taunk P. Predictors of Post ERCP Pancreatitis: analysis of more than half a million ERCPs performed Nationwide over the last 15 years: 57. Official J Am Coll Gastroenterol | ACG. 2018;113:35.
43.
go back to reference Abbas A, Sethi S, Vidyarthi G, Taunk P. Training level (July Effect) and the risk of Post-ERCP pancreatitis: a nationwide analysis of more than half a million ERCP procedures: 56. Official J Am Coll Gastroenterol | ACG. 2018;113:34.CrossRef Abbas A, Sethi S, Vidyarthi G, Taunk P. Training level (July Effect) and the risk of Post-ERCP pancreatitis: a nationwide analysis of more than half a million ERCP procedures: 56. Official J Am Coll Gastroenterol | ACG. 2018;113:34.CrossRef
44.
go back to reference Carbonell AM, Lincourt AE, Kercher KW, Matthews BD, Cobb WS, Sing RF, et al. Do patient or hospital demographics predict cholecystectomy outcomes? A nationwide study of 93,578 patients. Surg Endoscopy Other Interventional Techniques. 2005;19(6):767–73.CrossRef Carbonell AM, Lincourt AE, Kercher KW, Matthews BD, Cobb WS, Sing RF, et al. Do patient or hospital demographics predict cholecystectomy outcomes? A nationwide study of 93,578 patients. Surg Endoscopy Other Interventional Techniques. 2005;19(6):767–73.CrossRef
45.
go back to reference Mutneja HR, Vohra I, Go A, Bhurwal A, Katiyar V, Palomera Tejeda E, et al. Temporal trends and mortality of post-ERCP pancreatitis in the United States: a nationwide analysis. Endoscopy. 2020;53(04):357–66.PubMed Mutneja HR, Vohra I, Go A, Bhurwal A, Katiyar V, Palomera Tejeda E, et al. Temporal trends and mortality of post-ERCP pancreatitis in the United States: a nationwide analysis. Endoscopy. 2020;53(04):357–66.PubMed
46.
go back to reference Afridi F, Rotundo L, Feurdean M, Ahlawat S. Trends in Post-Therapeutic Endoscopic Retrograde Cholangiopancreatography gastrointestinal hemorrhage, perforation and mortality from 2000 to 2012: a Nationwide Study. Digestion. 2019;100(2):100–8.PubMedCrossRef Afridi F, Rotundo L, Feurdean M, Ahlawat S. Trends in Post-Therapeutic Endoscopic Retrograde Cholangiopancreatography gastrointestinal hemorrhage, perforation and mortality from 2000 to 2012: a Nationwide Study. Digestion. 2019;100(2):100–8.PubMedCrossRef
Metadata
Title
Epidemiology and outcomes of choledocholithiasis and cholangitis in the United States: trends and urban-rural variations
Authors
Suqing Li
Leonardo Guizzetti
Christopher Ma
Abdel Aziz Shaheen
Elijah Dixon
Chad Ball
Sachin Wani
Nauzer Forbes
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02868-3

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.